We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

001450:KRXHyundai Marine & Fire Insurance Co., Ltd. Analysis

Data as of 2026-03-17 - not real-time

₩30,050.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Hyundai Marine & Fire Insurance trades around KRW 30,050, well below its 20‑day SMA of KRW 32,862 and the industry‑average PE of 16.5, indicating a substantial valuation gap. Forward PE of 2.57 and a price‑to‑sales multiple of 0.15 suggest the stock is undervalued relative to peers. Revenue growth remains healthy at 8.4% YoY, but the latest earnings call revealed a 45.6% drop in net income and a 62% plunge in total insurance service results, highlighting short‑term earnings pressure. The balance sheet is bolstered by a massive cash pile (≈ KRW 35 trillion) that dwarfs total debt, providing a solid liquidity cushion despite negative free cash flow. Technicals show the price above the 200‑day SMA, supporting a long‑term bullish bias, while the RSI near 44 and a bearish MACD histogram signal near‑term caution. Volume has been contracting, and 30‑day volatility is high at 66%, implying heightened price swings. The market sentiment index is in “Extreme Greed” territory, and analysts (19) maintain a “Buy” consensus with a median target of KRW 36,000, implying ~20% upside. Overall, the stock offers a compelling entry point for value‑oriented investors, but the recent earnings decline and cash‑flow weakness warrant careful monitoring.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near strong support at KRW 28,650
  • Significant valuation upside (~19%)
  • Technical bullish bias despite MACD bearishness

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust cash reserves offsetting debt
  • Analyst consensus and target price indicating upside
  • Revenue growth sustaining earnings recovery

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Undervalued multiples relative to industry peers
  • Strong balance sheet with low beta (0.35) reducing market risk
  • Potential for steady cash‑flow generation as earnings normalize

Key Metrics & Analysis

Financial Health

Revenue Growth8.40%
Profit Margin6.58%
P/E Ratio2.6
ROE20.19%
ROA1.69%
Debt/Equity72.67
Op. Cash Flow₩1780.7B
Free Cash Flow₩-3688710799360
Industry P/E16.5

Technical Analysis

TrendBullish
RSI44.5
Support₩28,650.00
Resistance₩44,250.00
MA 20₩32,862.50
MA 50₩30,352.00
MA 200₩28,257.75
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair Value₩710,865.08
Target Price₩35,736.84
Upside/Downside18.92%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.35
Volatility66.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.